Direct Production of 5-Oxo Derivatives of Avermectins by a Recombinant Strain of Streptomyces avermitilis
Sir:
Avermectins are a family of oleandrose disaccharide derivatives of sixteen-membered macrolides with potent anthelmintic and insecticidal activities produced by Streptomyces avermitilis^.
A large number of avermectin derivatives have been prepared by a variety of techniques, including mutagenesis2), biotransformation3), mutational biosynthesis4* and chemical modification5*. The main purposes for preparation of such derivatives are enhanced potency, broader spectrum and lower toxicity. Ivermectin, 22,23-dihydroavermectin B l , has been prepared chemically from avermectin Bl components to attain enhanced potency. Milbemycins6), which are structurally related to avermectins, have been also modified for similar purposes. 5-Oximederivatives of milbemycins have enhanced potency7'8*. 5-Oxime derivatives of avermectins have also more potent activities. The synthesis of 5-oxime derivatives of the above both compoundsneeds at least two steps, in which the hydroxyl group at the C-5 position of the aglycone moiety is selectively oxidized by active manganese dioxide to form 5-oxo derivatives and then the keto residue is reacted with hydroxylamine to convert to 5-oxime derivatives7*.
In these steps, oximation of 5-oxo derivatives is a quantitative reaction but selective oxidation of the hydroxyl group at C-5 of avermectins and milbemycins gives a lower yield7'9*. The yield of the selective oxidation of the hydroxyl residue at C-5 of avermectin B components was 40 to 60%. If we could get a strain that produces 5-oxoavermectins directly, 5-oxime derivatives of avermectins would be efficiently and easily constructed.
The biosynthetic pathway to avermectins after the formation of the aglycones has been proposed by us10* and the Merck group5'11*. After condensation of fatty acids by polyketide synthase, 6,8a-seco-6,8a-deoxy-5-oxoavermectin aglycone is formed by the gene products of aveAI, AHand aveC. The cyclization takes place between C-6 and C-8a positions catalyzed by the gene product of aveE to form 5-oxoavermectin aglycone. The keto group at C-5 position is reduced to form avermectin aglycone. Glycosylation at the C-13 position by the gene product of aveB and O-methylation at C-5 by the gene product of aveD then take place to form avermectins.
Almost all mutants have been obtained, however, the mutant whichlacks the activity of reduction of the keto residue at C-5 position of the aglycone has never been isolated. Such mutant would be expected to produce 5-oxoavermectins because aveE mutant produces 6,8a-seco-6,8a-deoxy-5-oxoavermectin B glycosylated at the C-13 position12*.
During analysis of the gene cluster for avermectin biosynthesis,
we have' found the fegion responsible for the reduction at the C-5 keto residue13). We have attempted a frame shift mutation in this region on the chromosomeof the wild type strain Streptomyces avermitilis K139. The resulting recombinant strain did not produce any natural avermectins, but did produce new components different from natural avermectins (Fig.   1 ). To elucidate their structures, the recombinant strain (K2082) was cultivated in a liquid production medium as described previously14" 16* and the new components were isolated from the cultured broth. were similar to 4'-deoleandrosyl-6,8a-seco-6,8a-deoxy-5-oxoavermectin Bla and B2a12). These structures were Both sugars are a-L-oleandrose.
-Oxoavermectins
determined by comparing their NMRspectra with those of natural avermectins. From the analysis of 400-MHz *H NMR,all compounds isolated from the recombinant strain K2082 were shown to lack a proton at the C-5 position, and identical down field shifts in the chemical shifts of H-2, H-3, and H-6 indicated the conversion of an allylie alcohol to an a,/?-unsaturated ketone. Themass spectra of these compoundsalso agree with loss of two hydrogen atoms from C-5 and its substituent OH. Other NMRdata were similar to those of natural avermectins. These results show that the above four compounds 1, 2, 3 and 4 obtained from the recombinant strain K2082 are identical with 5-oxoavermectins Bla, Bib, B2a and B2b, respectively ( Fig.  2) , which have been chemically synthesized by Chabala et al9). Thus, a producer (K2082) of 5-oxoavermectins was constructed successfully by the specific disruption of the gene for the C-5 keto reduction step without affecting the productivity in the avermectin producer S. avermitilis. 
